REG - Induction Healthcare - Grant of Options

Induction HealthcareAnnouncement

17/07/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240717:nRSQ6585Wa&default-theme=true

RNS Number : 6585W  Induction Healthcare Group PLC  17 July 2024

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

 

Grant of Options

 

London, UK - 17 July 2024: Induction Healthcare Group PLC (AIM: INHC), a
leading digital health platform driving the transformation of healthcare
systems, announces that following the announcement of the FY24 results and
having met the criteria for the granting of options, on 15 July 2024 it
granted, in aggregate, 850,000 options to Paul Tambeau (Chief Executive
Officer) and John McIntosh (Chief Financial Officer) under the Company's
Non-Tax Advantaged Share Option Plan.

 

The Options have an exercise price of 0.5 pence (equivalent to the nominal
value of the Ordinary Shares) and, began vesting on 5 July 2024. 33.33% of the
Options shall vest on the 5 July 2025, following which equal portions shall
vest every three months across a twenty-four-month period.

 

Following this grant of Options, Induction has 2,400,000 Options in issue,
representing approximately 2.56 per cent. of the Company's issued share
capital.

 

Enquiries

 

 Induction

 Christopher Samler, Chair               +44 (0)7712 194092

 Paul Tambeau, Chief Executive Officer   +44 (0)7983 104443

 Singer Capital Markets (Nominated Adviser and Broker)                +44 (0)20 7496 3000
 Philip Davies

 Alaina Wong

 Finn Gordon

 

About Induction - www.inductionhealthcare.com
(http://www.inductionhealthcare.com/)

Induction (AIM: INHC) Induction delivers a suite of software solutions through
a single integrated platform that transforms care delivery. Our system-wide
applications help healthcare providers and administrators to deliver care at
any stage remotely as well as face-to-face - giving the communities they serve
greater flexibility, control and ease of access. Purpose-built for integration
with leading Electronic Medical Record (EMR) platforms, our products offer
immediate stand-alone value that becomes even greater when integrated with
pre-existing systems.

 

Used at scale by national and regional healthcare systems, as well non-health
government services, our applications are relied upon by hundreds of thousands
of clinicians and millions of patients across almost every hospital in the
British Isles.

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

 

 1.    Details of the person discharging managerial responsibilities / person closely
       associated
 a.    Name                                                         1.    Paul Tambeau - Chief Executive Officer

                                                                    2.    John McIntosh - Chief Financial Officer
 2.    Reason for the notification
 a.    Position/status                                              As above.
 a.    Initial notification                                         Initial notification

       /Amendment
 3.    Details of the issuer, emission allowance market participant, auction
       platform, auctioneer or auction monitor
 a.    Name                                                         Induction Healthcare Group PLC
 b.    LEI                                                          213800RY96GCZQW5TP19
 4.    Details of the transaction(s): section to be repeated for (i) each type of
       instrument; (ii) each type of transaction; (iii) each date; and (iv) each
       place where transactions have been conducted
 a.    Description of the Financial instrument, type of instrument  Ordinary shares of 0.5 pence each

       Identification code

                                                                    GB00BJ0M3545
 b.    Nature of the transaction                                    Grant of share options
 c.    Price(s) and volume(s)                                       PDMR                        Volume(s)     Price(s)
                                                                    1.    Paul Tambeau          500,000       Nominal Value
                                                                    2.    John McIntosh         350,000       Nominal Value
 d.    Aggregated information                                        N/A - single transactions

       Aggregated volume

       Price
 e.    Date of the transaction                                      15-07-24
 f.    Place of the transaction                                     Off-Exchange

d.

Aggregated information

Aggregated volume

Price

 N/A - single transactions

e.

Date of the transaction

15-07-24

f.

Place of the transaction

Off-Exchange

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHBLGDRRUBDGSL